Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France
Authors:
- Corentin PoignonCPCorentin Poignon
- Frédéric VandenbosFVFrédéric Vandenbos
- Karine RissoKRKarine Risso
- Delphine ViardDVDelphine Viard
- Esther GydéEGEsther Gydé
- Alice GaudartAGAlice Gaudart
- David ChirioDCDavid Chirio
- Nicolas VezirisNicolas Veziris
- Michel CarlesMCMichel Carles
Open Access
- 1 March 2026
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 32 (3) , 449-451
Abstract
Occupational Transmission of Extensively Drug-Resistant Tuberculosis, FranceKeywords
This publication has 10 references indexed in Scilit:
- Estimating the Early Transmission Inhibition of New Treatment Regimens for Drug-Resistant TuberculosisThe Journal of Infectious Diseases, 2025
- 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseasesAnnals of the Rheumatic Diseases, 2022
- Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquilineThe International Journal of Tuberculosis and Lung Disease, 2022
- ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2021
- Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Alimentary Pharmacology & Therapeutics, 2018
- Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor InhibitorAnnals of the American Thoracic Society, 2016
- Incidence of tuberculosis among nurses and healthcare assistants in FranceOccupational Medicine, 2016
- Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID CohortJournal of Crohn's and Colitis, 2016
- Tuberculosis among Health Care WorkersEmerging Infectious Diseases, 2011
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001